KLRC1 and Miyoshi myopathy: Moreover, focusing on HLA-E, increased NK cell degranulation against CX-5461-treated MM PCs in the presence of an NKG2A-blocking monoclonal antibody, corroborated the findings obtained with cell lines, in an autologous setting (Supplementary Fig. 9E).